Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models

Kenta Kawasaki, Masayuki Fujii, Toshiro Sato

研究成果: Review article査読

41 被引用数 (Scopus)


Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) refer to a group of heterogeneous cancers of neuroendocrine cell phenotype that mainly fall into one of two subtypes: gastroenteropancreatic neuroendocrine tumors (GEP-NETs; well differentiated) or gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs; poorly differentiated). Although originally defined as orphan cancers, their steadily increasing incidence highlights the need to better understand their etiology. Accumulating epidemiological and clinical data have shed light on the pathological characteristics of these diseases. However, the relatively low number of patients has hampered conducting large-scale clinical trials and hence the development of novel treatment strategies. To overcome this limitation, tractable disease models that faithfully reflect clinical features of these diseases are needed. In this Review, we summarize the current understanding of the genetics and biology of these diseases based on conventional disease models, such as genetically engineered mouse models (GEMMs) and cell lines, and discuss the phenotypic differences between the models and affected humans. We also highlight the emerging disease models derived from human clinical samples, including patient-derived xenograft models and organoids, which may provide biological and therapeutic insights into GEP-NENs.

ジャーナルDMM Disease Models and Mechanisms
出版ステータスPublished - 2018 2月

ASJC Scopus subject areas

  • 神経科学(その他)
  • 医学(その他)
  • 免疫学および微生物学(その他)
  • 生化学、遺伝学、分子生物学一般


「Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。